Clinical Everolimus Experience in Pediatric Renal Transplant Patients


DINCEL N., BULUT I. K. , SEZER T. Ö. , MIR S., HOSCOSKUN C.

TRANSPLANTATION PROCEEDINGS, cilt.45, ss.913-916, 2013 (SCI İndekslerine Giren Dergi)

Özet

Objective. Everolimus is a potent immunosuppressive agent that has antiproliferative activities. This study sought to share our experience among renal transplanted children who required conversion from calcineurin inhibitors (CNIs) to the mammalian target of rapamycin inhibitor everolimus.